2020
DOI: 10.1016/j.clineuro.2020.105734
|View full text |Cite
|
Sign up to set email alerts
|

Clinical features of collagen VI-related dystrophies: A large Brazilian cohort

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

2
7
1

Year Published

2021
2021
2024
2024

Publication Types

Select...
5
1

Relationship

0
6

Authors

Journals

citations
Cited by 9 publications
(12 citation statements)
references
References 29 publications
2
7
1
Order By: Relevance
“…From the genetic information, we have established the mutation pro le of the largest cohort at a single center as far as we are aware. The majority of the variants were mono-allelic (86%, 120/140), and 67% (94/140) of them were likely to be de novo because the parents of the patients were not affected, as has previously been described [6,9,10,17,18]. Therefore, our mutation pro le may be useful as a reference for diverse ethnicities.…”
Section: Resultsmentioning
confidence: 56%
See 1 more Smart Citation
“…From the genetic information, we have established the mutation pro le of the largest cohort at a single center as far as we are aware. The majority of the variants were mono-allelic (86%, 120/140), and 67% (94/140) of them were likely to be de novo because the parents of the patients were not affected, as has previously been described [6,9,10,17,18]. Therefore, our mutation pro le may be useful as a reference for diverse ethnicities.…”
Section: Resultsmentioning
confidence: 56%
“…Mono-allelic variants in the THD must be primarily associated with the majority SSCD staining pattern (91%, 92/101) and UCMD phenotype (90%, 94/105), whilst mono-allelic variants outside the THD were also associated with SSCD (71%, 10/14) but a BM phenotype (93%, 14/15). In exceptional cases, genotypes cannot be associated with speci c phenotypes, with some variants reported to cause both UCMD and BM phenotypes [9][10][11]18]. In fact, in our cohort, the families with c.877G>A in COL6A1, c.856-2A>G in COL6A2, or c.943G>A in COL6A2 showed a wide range of phenotypes from milder BM to severer UCMD, while conversely the variation in phenotypes of families with c.956A>G or c.1022G>A in COL6A1 was quite narrow and on the border between UCMD and BM.…”
Section: Resultsmentioning
confidence: 99%
“…From the genetic information, we have established the causative variant profile of the largest cohort at a single center as far as we are aware. The majority of the variants were mono-allelic (86%, 120/140), and 67% (94/140) of them were likely to be de novo because the parents of the patients were not apparently affected and their DNAs were not available, as has previously been described [ 11 , 14 , 15 , 22 24 ]. Therefore, our causative variant profile may be useful as a reference for diverse ethnicities.…”
Section: Discussionmentioning
confidence: 98%
“…In contrast, mono-allelic variants outside the THD were also associated with SSCD (71%, 10/14) but a BM phenotype (93%, 14/15) (Table 2 ). However, as shown in the literatures, genotypes cannot be associated with specific phenotypes, with some variants reported to cause both UCMD and BM phenotypes [ 14 16 , 24 ]. In fact, in our cohort, the families with c.877G>A in COL6A1 , c.856-2A>G in COL6A2 , or c.943G>A in COL6A2 showed a wide range of phenotypes from milder BM to severer UCMD, while conversely the variation in phenotypes of families with c.956A>G or c.1022G>A in COL6A1 was quite narrow and those families showed BM or intermediate phenotypes.…”
Section: Discussionmentioning
confidence: 99%
“…[ 15 ] In cohort studies conducted to date, hypertension has not been reported in patients with COL6-related myopathy. [ 2 16 ] van der Kooi and colleagues did not find any cardiac abnormality in a Dutch family with COL6A2 mutation. [ 17 ] Only, Bao and colleagues reported a patient with recurrent hematuria, and after whole-exome sequencing analysis, they speculated that impaired interaction between COL6 and COL4 results in haematuria.…”
Section: Discussionmentioning
confidence: 99%